CA Stock MarketDetailed Quotes

METX ME Therapeutics Holding Inc

Watchlist
  • 3.850
  • -0.050-1.28%
15min DelayMarket Closed Nov 18 15:38 ET
96.98MMarket Cap-24679P/E (TTM)

ME Therapeutics Holding Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)May 31, 2024
(Q2)Feb 29, 2024
(Q1)Nov 30, 2023
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(Q3)May 31, 2023
(Q1)Dec 31, 2022
(FY)Aug 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
2.58%-142.98K
-99.25K
-1,078.96%-265.43K
-123.46%-303.2K
-100.9K
-146.77K
-22.51K
-135.69K
Net income from continuing operations
85.81%-495.99K
---143.49K
-431.40%-343.11K
-4,372.64%-6.52M
---2.95M
---3.49M
---64.57K
---145.78K
Depreciation and amortization
-16.67%10
--11
--9
-19.67%49
--12
--12
----
--61
Remuneration paid in stock
-10.11%305.5K
--6.92K
--207.6K
4,198.90%588.22K
--248.35K
--339.87K
----
--13.68K
Other non cashItems
-99.96%1.25K
--2.93K
--4.4K
51,625.44%5.59M
--2.58M
--2.99M
----
--10.8K
Change In working capital
129.20%46.25K
--34.38K
-419.42%-134.33K
394.77%42.58K
--13.82K
--20.18K
--42.05K
---14.45K
-Change in receivables
-228.20%-5.05K
--22.98K
---23.78K
175.05%15.42K
---1.04K
---1.54K
----
---20.55K
-Change in prepaid assets
-81.57%4.55K
--49.95K
---40.63K
-583.97%-15.1K
---15.32K
--24.7K
----
---2.21K
-Change in payables and accrued expense
1,665.61%46.75K
---38.56K
-266.26%-69.92K
408.48%42.26K
--30.18K
---2.99K
--42.05K
--8.31K
Cash from discontinued investing activities
Operating cash flow
2.58%-142.98K
---99.25K
-1,078.96%-265.43K
-123.46%-303.2K
---100.9K
---146.77K
---22.51K
---135.69K
Investing cash flow
Cash flow from continuing investing activities
757.44K
0
0
Net business purchase and sale
----
----
----
--757.44K
--0
----
----
--0
Cash from discontinued investing activities
Investing cash flow
----
----
----
--757.44K
--0
----
----
--0
Financing cash flow
Cash flow from continuing financing activities
450K
-17.48%115.53K
115.53K
0
125K
140K
Net issuance payments of debt
--0
----
----
--0
--0
--0
----
--140K
Net common stock issuance
----
----
----
--115.53K
----
----
--125K
--0
Cash from discontinued financing activities
Financing cash flow
--450K
----
----
-17.48%115.53K
--115.53K
--0
--125K
--140K
Net cash flow
Beginning cash position
6,066.33%1.35M
--381.72K
62.64%647.15K
5.91%77.38K
--632.52K
--21.85K
--397.91K
--73.06K
Current changes in cash
-49.72%307.02K
--965.75K
-358.99%-265.43K
13,104.36%569.77K
--14.62K
--610.67K
--102.49K
--4.32K
End cash Position
161.57%1.65M
--1.35M
-23.72%381.72K
736.35%647.15K
--647.15K
--632.52K
--500.4K
--77.38K
Free cash from
2.58%-142.98K
---99.25K
-1,078.96%-265.43K
-123.46%-303.2K
---100.9K
---146.77K
---22.51K
---135.69K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(Q3)May 31, 2024(Q2)Feb 29, 2024(Q1)Nov 30, 2023(FY)Aug 31, 2023(Q4)Aug 31, 2023(Q3)May 31, 2023(Q1)Dec 31, 2022(FY)Aug 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 2.58%-142.98K-99.25K-1,078.96%-265.43K-123.46%-303.2K-100.9K-146.77K-22.51K-135.69K
Net income from continuing operations 85.81%-495.99K---143.49K-431.40%-343.11K-4,372.64%-6.52M---2.95M---3.49M---64.57K---145.78K
Depreciation and amortization -16.67%10--11--9-19.67%49--12--12------61
Remuneration paid in stock -10.11%305.5K--6.92K--207.6K4,198.90%588.22K--248.35K--339.87K------13.68K
Other non cashItems -99.96%1.25K--2.93K--4.4K51,625.44%5.59M--2.58M--2.99M------10.8K
Change In working capital 129.20%46.25K--34.38K-419.42%-134.33K394.77%42.58K--13.82K--20.18K--42.05K---14.45K
-Change in receivables -228.20%-5.05K--22.98K---23.78K175.05%15.42K---1.04K---1.54K-------20.55K
-Change in prepaid assets -81.57%4.55K--49.95K---40.63K-583.97%-15.1K---15.32K--24.7K-------2.21K
-Change in payables and accrued expense 1,665.61%46.75K---38.56K-266.26%-69.92K408.48%42.26K--30.18K---2.99K--42.05K--8.31K
Cash from discontinued investing activities
Operating cash flow 2.58%-142.98K---99.25K-1,078.96%-265.43K-123.46%-303.2K---100.9K---146.77K---22.51K---135.69K
Investing cash flow
Cash flow from continuing investing activities 757.44K00
Net business purchase and sale --------------757.44K--0----------0
Cash from discontinued investing activities
Investing cash flow --------------757.44K--0----------0
Financing cash flow
Cash flow from continuing financing activities 450K-17.48%115.53K115.53K0125K140K
Net issuance payments of debt --0----------0--0--0------140K
Net common stock issuance --------------115.53K----------125K--0
Cash from discontinued financing activities
Financing cash flow --450K---------17.48%115.53K--115.53K--0--125K--140K
Net cash flow
Beginning cash position 6,066.33%1.35M--381.72K62.64%647.15K5.91%77.38K--632.52K--21.85K--397.91K--73.06K
Current changes in cash -49.72%307.02K--965.75K-358.99%-265.43K13,104.36%569.77K--14.62K--610.67K--102.49K--4.32K
End cash Position 161.57%1.65M--1.35M-23.72%381.72K736.35%647.15K--647.15K--632.52K--500.4K--77.38K
Free cash from 2.58%-142.98K---99.25K-1,078.96%-265.43K-123.46%-303.2K---100.9K---146.77K---22.51K---135.69K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data